Validation of a commercial software dose calculation for Y-90 microspheres



      Several new commercial software packages have become available that can calculate the tumor and normal tissue dose distributions from post-treatment PET-CT scans for Y-90 microsphere treatments of liver lesions. This work seeks to validate the MIM SurePlan Liver Y90 software by comparing its results to a previously developed Monte Carlo derived voxel dose kernel calculation method.


      We analyzed 10 patients who had treatments for metastatic liver cancer and created contours on post Y-90 treatment PET-CT images. We then performed dose calculations using three methods and compared the results. The first two methods calculated the dose using MIM SurePlan Liver Y90’s LDM (Local Deposition Method) and the VSV (Voxel S Value) algorithms. The third method calculated the dose using a publicly available Fluka Monte Carlo-derived dose kernel (MCK) calculation (used as ground truth). We investigated 3D Gamma passing rates and several dosimetric parameters.


      A total of 3%/3 mm 3D gamma passing rates averaged 99.3% for the VSV and 78.9% for LDM. Compared to the MCK distribution, the differences for combined target GTV V70Gy and normal liver and/or lobe mean doses were small. Larger differences were seen in GTV mean doses and D95, likely due to large dose gradients in the treated regions combined with differences in dose kernel, dose grid and finite volume effects.


      The MIM SurePlan Liver Y90 VSV algorithm agreed well with the MCK calculation for patients treated with Y-90 microspheres based on the gamma analysis and several dosimetric parameters. Larger dosimetric differences in lesion mean doses and D95 suggests that these metrics are less robust to changes in calculation grid location and finite volume effects for small lesions.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dezarn W.A.
        • Cessna J.T.
        • DeWerd L.A.
        • et al.
        American Association of Physicists in Medicine: recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies.
        Med. Phys. 2011; 38: 4824-4845
        • Badiyan S.
        • Bhooshan N.
        • Chuong M.D.
        • et al.
        Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres.
        Nucl Med Commun. 2018; 39: 915-920
        • Maughan N.M.
        • Garcia-Ramirez J.
        • Arpidone M.
        • et al.
        Validation of post-treatment PET-based dosimetry software for hepatic radioembolization of Yttrium-90 microspheres.
        Med. Phys. 2019; 46: 2394-2402
        • Bolch W.E.
        • Bouchet L.G.
        • Robertson J.S.
        • et al.
        “MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions–radionuclide S values at the voxel level”. Medical Internal Radiation Committee.
        J Nucl Med. 1999 Jan; 40: 11S-36S
        • Balagopal A.
        • Kappadath S.C
        Characterization of 90 Y-SPECT/CT self-calibration approaches on the quantification of voxel-level absorbed doses following 90 Y-microsphere selective internal radiation therapy.
        Med. Phys. 2018; 45: 875-883
        • Fourkal E.
        • Veltchev I.
        • Lin M.
        • et al.
        3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study.
        Med. Phys. 2013; 40081702
        • Veltchev I.
        • Fourkal E.
        • Doss M.
        • et al.
        SU-E-T-189: first experimental verification of the accuracy of absolute dose reconstruction from PET-CT imaging of Yttrium 90 microspheres.
        Med. Phys. 2014; 41: 266
      1. I. Veltchev, E. Fourkal, M. Doss, et al. SU-F-BRA-15: physical aspects and clinical applications of post-treatment yttrium-90 PET-based dosimetry 2022.

        • Johnson Matthew E.
        • Fourkal Eugene
        • Veltchev Iavor
        • et al.
        (P061) activity verification and localization using PET-CT for patients treated with radioembolization.
        Oncology. 2022; 28 (P061)
        • Nelson Aaron
        • Swallen Amy
        • Arpidone Matt
        • Nelson Dennis
        Dosimetry For Y-90 Microsphere brachytherapy.
        MIM Software Inc. White Paper (private communication), 2018
        • Low D.A.
        • Harms W.B.
        • Mutic S.
        • Purdy J.A.
        A technique for the quantitative evaluation of dose distributions.
        Med. Phys. 1998; 25: 656-661
        • Chang C.
        • Poole K.L.
        • Teran A.V.
        • et al.
        Three-dimensional gamma criterion for patient-specific quality assurance of spot scanning proton beams.
        J Appl Clin Med Phys. 2015; 16: 381-388
      2. Pirlepesov F., Yao W., Zhao L., et al. Comparison of 3D and 2D gamma tests for patient-specific proton pencil-beam scanning quality assurance. (Private Communication) 2022.

        • Yao W.
        • Moskvin V.
        • Zhao L.
        • et al.
        Implementation of a simplified analytical random walk model dose calculation algorithm with nuclear interaction for treatment planning of scanning-beam proton therapy.
        Biomedical Physics & Engineering Express. 2018; 4035023
        • Pasciak Alexander S.
        • Erwin William D.
        Effect of voxel size and computation method on Tc-99 m MAA SPECT/CT-based dose estimation for Y-90 microsphere therapy.
        IEEE Trans Med Imaging. 2009; 28: 1754-1758
        • Siman W.
        • Mikell J.K.
        • Mawlawi O.R.
        • et al.
        Dose volume histogram-based optimization of image reconstruction parameters for quantitative 90Y-PET imaging.
        Med Phys. 2019; 46: 229-237
        • Chiesa C.
        • Sjogreen-Gleisner K.
        • Walrand S.
        • et al.
        EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre-and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres.
        EJNMMI Phys. 2021; 8: 1-44
        • Kappadath S.C.
        • Mikell J.
        • Balagopal A.
        • et al.
        Hepatocellular carcinoma tumor dose response after 90Y-radioembolization with glass microspheres using 90Y-SPECT/CT-Based Voxel Dosimetry.
        Intern J Radiation Oncol Biol Physics. 2018; 102: 51-461